发明名称 Inhibiting Eph B-3 kinase
摘要 EphB3 kinase inhibitor compounds, including certain pyrazolo[1,5-a]pyridine and imidazo[1,2-a]pyridine compounds, inhibit EphB3 kinase. The EphB3 kinase inhibitor compounds can have greater potency for the inhibition of EphB3 kinase than general kinase inhibitors. Pharmaceutical compositions, such as neuroprotective agents, comprising the EphB3 kinase inhibitor compounds are also provided. The EphB3 kinase inhibitor compounds and pharmaceutical compositions are useful, for example, to provide neuroprotection and/or repair of neuronal tissue damaged during an ischemic event, such as a stroke.
申请公布号 US8927545(B2) 申请公布日期 2015.01.06
申请号 US201013260990 申请日期 2010.03.30
申请人 Duke University;The Brigham and Women's Hospital, Inc. 发明人 Qiao Lixin;Glicksman Marcie;Gainer Thomas;Lo Donald C.;Stein Ross L.;Choi Sungwoon;Cuny Gregory D.
分类号 A61K31/535;C07D491/02;C07D498/02;C07D513/02;C07D515/02;A61K31/437;A61K31/00 主分类号 A61K31/535
代理机构 Fish & Richardson P.C. 代理人 Fish & Richardson P.C.
主权项 1. A pharmaceutical composition comprising a compound of formula (II): or a pharmaceutically acceptable salt thereof; wherein: R1′ is halogen;R2′ is selected from the group consisting of hydrogen and lower (C1-C8) alkyl; andR3′ is hydrogen, halogen, cycloalkyl, cycloheteroalkyl, aryl, or heteroaryl.
地址 Durham NC US